Clinical Trial

STep-up and Step-down Therapeutic Strategies in Childhood ARthritiS

Study acronym: STARS
Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated October 15, 2024 (before its estimated February 28, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to compare the effectiveness of a conventional therapeutic regimen, based on treatment escalation (step-up strategy) and driven by the treat-to-target approach, with that of an early aggressive intervention based on the initial start of a combination of conventional and biological DMARDs (step-down strategy).
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2018-10-31; most recent amendment 2024-10-09.
Status change: Not Yet Recruiting → Recruiting 2019-08-08
Trial Details
NCT Number NCT03728478
Lead Sponsor Istituto Giannina Gaslini
Collaborators: Agenzia Italiana del Farmaco, Compagnia di San Paolo, Pfizer
Conditions Oligoarthritis, Juvenile, Polyarthritis, Juvenile, Rheumatoid Factor Negative
Enrollment 260 participants
Start Date 2019-05-29
Primary Completion 2025-02-28 (estimated)
Study Completion 2025-02-28 (estimated)
Updated on ClinicalTrials.gov 2024-10-15